Equasens Société anonyme

ENXTPA:EQS Lagerbericht

Marktkapitalisierung: €823.7m

Equasens Société anonyme Management

Management Kriterienprüfungen 3/4

Equasens Société anonyme's CEO ist Denis Supplisson , ernannt in Apr 2022, hat eine Amtszeit von 2.17 Jahren. Die jährliche Gesamtvergütung beträgt €400.20K , bestehend aus 44.1% Gehalt und 55.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0% der Aktien des Unternehmens, im Wert von €582.91 . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.4 Jahre bzw. 12.5 Jahre.

Wichtige Informationen

Denis Supplisson

Geschäftsführender

€400.2k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts44.1%
Amtszeit als Geschäftsführer2.2yrs
Eigentum des Geschäftsführers0.00007%
Durchschnittliche Amtszeit des Managements1.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder12.5yrs

Jüngste Management Updates

Recent updates

Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Jun 22
Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Jun 07
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

Apr 03
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Mar 08
At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Feb 14
Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 27
Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

Nov 29
Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

Oct 28
These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Sep 27
A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Aug 05
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Jun 11
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 08
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Apr 04
What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Feb 13
Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 26
Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Dec 21
At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Dec 07
Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Nov 12
Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Oct 27
Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Oct 12
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

When Should You Buy Equasens Société anonyme (EPA:EQS)?

Sep 09
When Should You Buy Equasens Société anonyme (EPA:EQS)?

With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Aug 24
With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Jul 28
Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Jun 10
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

May 27
Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

May 22
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Apr 25
Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Feb 23
Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Feb 09
Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Jan 25
Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Jan 06
Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Nov 14
Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Oct 30
Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Sep 28
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Jul 18
Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Jun 24
Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Apr 08
Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Mar 24
Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 03
Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Feb 09
Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

Jan 12
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Dec 15
What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?

Dec 01
Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Denis Supplisson im Vergleich zu den Einnahmen von Equasens Société anonyme verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Dec 31 2023n/an/a

€47m

Jun 30 2023n/an/a

€48m

Mar 31 2023n/an/a

€47m

Dec 31 2022€400k€176k

€46m

Jun 30 2022n/an/a

€42m

Mar 31 2022n/an/a

€41m

Dec 31 2021€353k€133k

€39m

Sep 30 2021n/an/a

€37m

Jun 30 2021n/an/a

€35m

Mar 31 2021n/an/a

€33m

Dec 31 2020€371k€133k

€31m

Sep 30 2020n/an/a

€29m

Jun 30 2020n/an/a

€27m

Mar 31 2020n/an/a

€27m

Dec 31 2019€225k€133k

€27m

Sep 30 2019n/an/a

€27m

Jun 30 2019n/an/a

€26m

Mar 31 2019n/an/a

€26m

Dec 31 2018€208k€128k

€25m

Sep 30 2018n/an/a

€25m

Jun 30 2018n/an/a

€24m

Mar 31 2018n/an/a

€24m

Dec 31 2017€189k€114k

€23m

Vergütung im Vergleich zum Markt: DenisDie Gesamtvergütung ($USD429.72K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt French ($USD643.36K).

Entschädigung vs. Einkommen: DenisDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Denis Supplisson (55 yo)

2.2yrs

Amtszeit

€400,201

Vergütung

Mr. Denis Supplisson serves as Chief Executive Officer at Pharmagest Interactive SA since April 22, 2022. He served as Deputy Managing Director/Deputy Chief Executive Officer & Manager of the Europe Pharma...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Thierry Chapusot
Founder & Chairman of the Board14.4yrs€8.00k0.033%
€ 274.0k
Denis Supplisson
Chief Executive Officer & Director2.2yrs€400.20k0.000070%
€ 576.6
Dominique Pautrat
Directorno data€330.17k0.16%
€ 1.3m
Grégoire De Rotalier
Deputy CEO3.9yrs€411.35k0.000070%
€ 576.6
Frederique Schmidt
Group Chief Administrative & Financial Officer1.4yrskeine Datenkeine Daten
Noelle Stoulig
Head of Communicationsless than a yearkeine Datenkeine Daten
Sabrina Gharbi
Chief Human Resources Officer4.7yrskeine Datenkeine Daten
Dominique Goursaud
Head of the Medical Solutions Divisionless than a yearkeine Datenkeine Daten
Damien Valicon
Deputy MD & Head of the Pharmagest Divisionless than a yearkeine Datenkeine Daten

1.4yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: EQSDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.4 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Thierry Chapusot
Founder & Chairman of the Board14.4yrs€8.00k0.033%
€ 274.0k
Denis Supplisson
Chief Executive Officer & Director11.4yrs€400.20k0.000070%
€ 576.6
Dominique Pautrat
Director15yrs€330.17k0.16%
€ 1.3m
Grégoire De Rotalier
Deputy CEO3.9yrs€411.35k0.000070%
€ 576.6
Daniel Antoine
Director22.1yrs€6.91k0.0033%
€ 27.4k
Hugues Moreaux
Director13.4yrskeine Datenkeine Daten
François Jacquel
Director13.4yrs€5.60k0.0027%
€ 22.7k
Anne Lhote
Director13yrskeine Daten0.0037%
€ 30.1k
Sophie Mayeux
Independent Director12yrs€6.91k0.00017%
€ 1.4k
Celine Gris
Independent Director7yrs€6.15k0.00013%
€ 1.1k
Emilie Lecomte
Director7yrs€604.000.00011%
€ 906.1
Anne Philipona-Hintzy
Independent Directorless than a yearkeine Datenkeine Daten

12.5yrs

Durchschnittliche Betriebszugehörigkeit

57.5yo

Durchschnittliches Alter

Erfahrener Vorstand: EQSDie Vorstandsmitglieder sind sehr erfahren ( 12.5 ).